June 30th, 2022


Volume 41
Number 5
   
299
Mitchel S. Hoffman, M.D., Micah S. Harris, M.D., and Pierre J. Bouis, M.D.
Sacrospinous colpopexy was effective in reestablishing upper vaginal support after vaginal hysterectomy in patients with uterovaginal prolapse.


304
Shlomo Lipitz, M.D., Daniel S. Seidman, M.D., Reuwen Achiron, M.D., Mordechai Goldenberg, M.D., David Bider, M.D., and Shlomo Mashiach, M.D.
In selected cases, the use of transvaginal ultrasound guidance during operative laparoscopy is beneficial.


307
Joseph R. Feste, M.D.
In a high percentage of cases, electrosurgical loop excision offers the advantage (as compared to conventional punch biopsy) of diagnosing and treating premalignant lesions in a single visit.


313
Michael S. Opsahl, M.D., Nancy G. Dixon, Ph.D., M.D., Edwin R. Robins, M.D., and Dean S. Cunningham, M.D., Ph.D.
Analysis of multiple semen specimens provides a reliable screen in the evaluation of male factor infertility when the goal is to minimize the false negative rate of screening tests.


316
Fabio Parazzini, M.D., Eva Negri, Sc.D., Carlo La Vecchia, M.D., Manuela Rabaiotti, M.D., Laura Luchini, M.D., Antonella Villa, M.D., and Luigi Fedele, M.D.
Current smoking seems to reduce the risk of myomas.


321
Thomas L. Toth, M.D., Johnny T. Awwad, M.D., Lucinda L. Veeck, M.L.T., Howard W. Jones, Jr., M.D., and Suheil J. Muasher, M.D.
The flare regimen with gonadotropin-releasing hormone agonist is useful for ovarian hyperstimulation in women with elevated basal follicle-stimulating hormone values undergoing in vitro fertilization.


327
William Cusick, M.D., John F. Rodis, M.D., Anthony M. Vintzileos, M.D., S. Mark Albini, M.D., Megan McMahon and Winston A. Campbell, M.D.
In pregnancies with an unexplained elevated second-trimester MSAFP, the rate of adverse pregnancy outcomes is increased with higher elevations, mandating a strict program.


333
Mordechai Goldenberg, M.D., Eyal Sivan, M.D., David Bider, M.D., Shlomo Mashiach, M.D., and Daniel S. Seidman, M.D.
Endometrial resection, with its low cost and prompt recovery, offers a promising alternative treatment for women with abnormal uterine bleeding.


337
Harriette L. Hampton, M.D., B. Joyce Collins, B.S., M.S., Kenneth G. Perry, Jr., M.D., Edward F. Meydrech, Ph.D., Winfred L. Wiser, M.D., and John C. Morrison, M.D.
Third-year clerks tended to have higher National Board of Medical Examiner scores and final block grades in obstetrics-gynecology if they selected this rotation later in the academic year.


341
Kelle H. Moley, M.D., L. Stewart Massad, M.D., and David G. Mutch, M.D.
Pelvic inflammatory disease must be in the differential diagnosis of pelvic masses in reproductive-age women with history, clinical findings and markedly elevated CA-125 levels.


347
Simon Kipersztok, M.D., Marcia Javitt, M.D., Michael C. Hill, M.D., and Robert J. Stillman, M.D.
Hysterosalpingography remains the procedure of choice in the evaluation of diethylstilbestrol-associated uterine anomalies.


352
T. Yee Khong, M.D., and Michael M. S. Chin, B.M.B.S.
Subinvolution of the placental bed after molar pregnancy may be underdiagnosed after molar pregnancy and is a likely cause of continued bleeding following evacuation of the hydatidiform mole.


355
Robert L. Holley, M.D., R. Edward Varner, M.D., Brian P. Gleason, M.D., Lori A. Apffel, M.D., and Susan Scott, R.N.
In 36 women, sacrospinous ligament fixation and repair of associated pelvic support defects did not produce dyspareunia unless vaginal narrowing was present.


359
James O. Shirk, M.D., Pleas R. Copas, M.D., and Anthony A. Kattine, M.D.
This case was the first one of massive ovarian edema in a postmenopausal woman to be reported.


363
Damrong Tresukosol, M.D., Andrzej P. Kudelka, M.D., Creighton L. Edwards, M.D., Elvio G. Silva, M.D., Mahesh Kanojia, M.D., and John J. Kavanagh, M.D.
In this case of an ovarian serous tumor of low malignant potential, leuprolide acetate was effective as front-line therapy.


367
Lisa G. Shaffer, Ph.D., Aimee S. Spikes, B.A., Michelle Macha, B.S., and Randall Dunn, M.D.
The family described here exemplifies the need for good-quality cytogenetic analyses, given the multiple miscarriages and the infant who died with malformations.


372
Robert A. Hammer, M.D., Paul D. Urnes, M.D., and John R. Lurain, M.D.
A woman with ovarian function after radiotherapy for a retroperitoneal hemangiopericytoma gave birth to an infant with intrauterine growth retardation.


375
Daniel H. Tobias, M.D., Mordecai Koenigsberg, M.D., Melanie Kogan, M.D., Morris Edelman, M.D., and Michael LevGur, M.D.
This case illustrates that pyomyoma should be considered in the setting of a recent history of uterine instrumentation, signs of infection and a uterine myoma.


381
Daniel R. Mishell, Jr., M.D.
DMPA is a very effective form of contraception because of its multiple mechanisms of action and slow release into the circulation.


391
Anita L. Nelson, M.D.
This article provides a conceptual model for patient counseling, highlights the significant points that should be included in counseling patients about DMPA and offers clinical suggestions.


401
Carolyn Westhoff, M.D., M.Sc.
For metabolic parameters and mood changes, case reports indicating adverse clinical outcomes are nearly absent from the literature despite widespread long-term international use of DMPA.


407
Ann Jeanette Davis, M.D.
DMPA offers several distinct advantages over other contraceptive methods in adolescents, and satisfaction rates among adolesdent DMPA users is high.


414
Marilynn C. Frederiksen, M.D.
For women with certain medical problems, DMPA may offer distinct advantages.


419
Andrew M. Kaunitz, M.D.
Except for a substantial reduction in the risk of endometrial adenocarcinoma, use of DMPA does not appear to influence reproductive tract cancer risks.


428
Vanessa E. Cullins, M.D., M.P.H.
DMPA use is associated with reduced iron-deficiency anemia, protection against pelvic inflammatory disease, protection from endometrial cancer and improved hematologic parameters among users with sickle cell disease.


 

The opinions and statements in this journal are those of the authors and are not attributable to the sponsor, publisher, editors or editorial board of JRM. Product dosages, indications and methods of use referred to in the papers and discussions reflect the authors' clinical experience or are derived from other professional sources.